FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten

Cancer Immunology Immunotherapy

Volumn 45, Issue 6, 1998, Pages 334-339

  Capurro, Mariana ^a   Bover, Laura ^a,c   Portela, Paula ^a   Livingston, Philip ^b   Mordoh, José ^a,c  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Centro de Investigaciones Oncologicas FUCA   (Argentina)

Author keywords

Carcinoma; FC 2.15; Lewis(x); Monoclonal antibody; Neutrophils

Indexed keywords

ANTIGEN; ASPARAGINE LINKED OLIGOSACCHARIDE; EPITOPE; GLYCOPEPTIDASE; HAPTEN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; SIALIDASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTINYLATION; BLOOD GROUP LEWIS SYSTEM; BREAST CANCER; CANCER IMMUNOLOGY; CHRONIC MYELOID LEUKEMIA; COLORECTAL CARCINOMA; COMPLEMENT DEPENDENT CYTOTOXICITY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031934951     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050451     Document Type: Article

References (23)

1. Alon R, Feizi T, Yuen CT, Fuhlbrigge RC, Springer TA (1995) Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J Immunol 154:5356
2. Ballare C, Barrio M, Portela P, Mordoh J (1995) Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells. Cancer Immunol Immunother 41:15
3. Bayer EA, Wilchek M (1980) The use of avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 26:1
4. Demetrick DJ, Herlyn D, Tretiak M, Creasey D, Clevers H, Donoso LA, Vennegoor CJ, Dixon WT, Jerry LM (1992) Melanoma-associated glycoprotein family: antigen identity of ME491, NKI/C-3, neuroglandular antigen (NGA), and CD63 proteins. J Natl Cancer Inst 84:422
5. x from a phage display library. J Immunol 157:732
6. Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC (1984) Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes. J Biol Chem 259:10925
7. Gooi HC, Thorpe S, Hounsell EF, Rumpold H, Kraft D, Forster O, Feizi T (1983) Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur J Immunol 13:306
8. Guarino A, Cohen M, Thompson M, Dharmsthaphorn K, Giannella R (1987) T84 cell receptor binding and guanyl cyclase activation by Escherichia coli heat-stable toxin. Am J Physiol 253:G775
9. Hawkes R, Niday E, Gordon JA (1982) Dot-Immunobinding assay for monoclonal and other antobodies. Anal Biochem 119:142
10. Huang LC, Civin CI, Magnani JL, Shaper JH, Ginsburg V (1983) My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in Lacto-N-fucopentaose III. Blood 61:1020
11. Laemmli UK (1971) Cleavage of structural proteins during assembly of a head bacteriophage T4. Nature 227:680
12. Livingston PO, Adluri S, Helling F, Yao T-Y, Kensil CR, Newman M, Marciani D (1994). Phase I trial of the immunological adjuvant QS-21 with a GM2 ganlgioside-keyhole limpet hemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 12:1275
13. Lloyd KO, Kabat EA, Layug EJ, Gruezo F (1996) Immunochemical studies on blood groups. XXXIV. Structures of some oligosaccharides produced by alkaline degradation of blood groups A, B, and H substances. Biochemistry 5:1489
14. Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM (1990) ELAM-1 dependent cell adhesion to vascular endothelium determined by a transfected human fucosyl transferase cDNA. Cell 63:475
15. Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, Kairiyama C, Bover L (1995) Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias. Int J Biol Markers 9:125
16. Mordoh J, Silva C, Albarellos M, Bravo AI, Kairiyama C (1995) Phase I clinical trial in cancer patients of a new monoclonal antibody FC-2.15 reacting with tumor proliferating cells. J Immunother 17:151
17. Ragupathi G, Park TK, Zhang S, Kim JJ, Graebber K, Adluri S, Lloyd KO, Danishefsky SJ, Livingston PO (1997) Immunization of mice with the synthetic hexasaccharide Globo H results in antibodies against human cancer cells. Angew Chemie 36:125
18. Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J (1987) Subpopulations of MCF-7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci USA 84:7295
19. Solter D, Knowles B (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75:5565
20. Soule HD, Vazquez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409
21. Spooncer E, Fukuda M, Klock JC, Oates JE, Dell A (1984) Isolation and characterization of polyfucosylated lactosaminoglycans from human granulocytes. J Biol Chem 259:4792
22. Urbanski R, Carrithers SL, Waldman SA (1995) Internalization of E. coli ST mediated by guanylyl cyclase C in T84 human colon carcinoma cells. Biochim Biophys Acta 1245:29
23. Urdal DL, Brentnall TA, Bernstein ID, Hakomori SI (1983) A granulocyte reactive monoclonal antibody. IG10, identifies the Galβ1-4 (Fucα1-3) GlcNAc (X determinant) expressed in HL60 cells on both glycolipid and glycoprotein molecules. Blood 62:1022